We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Randomised trial shows improved fibrosis outcomes with efimosfermin alfa in patients with steatohepatitis, suggesting better management options.
No takes yet. Share an insight, caveat, or question.
Noureddin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: